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Background: The identification of cancer-associated long non-coding RNAs and the investigation of their
molecular and biological functions are important for understanding the molecular biology and progression of
cancer. HOTAIR (HOX transcript antisense intergenic RNA) has been implicated in several cancers; however, its role in
non-small cell lung cancer (NSCLC) is unknown. The aim of the present study was to examine the expression
pattern of HOTAIR in NSCLC and to evaluate its biological role and clinical significance in tumor progression.
Methods: Expression of HOTAIR was analyzed in 42 NSCLC tissues and four NSCLC cell lines by quantitative
reverse-transcription polymerase chain reaction (qRT-PCR). Over-expression and RNA interference (RNAi) approaches
were used to investigate the biological functions of HOTAIR. The effect of HOTAIR on proliferation was evaluated by
MTT and colony formation assays, and cell migration and invasion were evaluated by transwell assays. Tail vein
injection of cells was used to study metastasis in nude mice. Protein levels of HOTAIR targets were determined by
western blot analysis. Differences between groups were tested for significance using Student’s t-test (two-tailed).
Results: HOTAIR was highly expressed both in NSCLC samples and cell lines compared with corresponding normal
counterparts. HOTAIR upregulation was correlated with NSCLC advanced pathological stage and lymph-node
metastasis. Moreover, patients with high levels of HOTAIR expression had a relatively poor prognosis. Inhibition of
HOTAIR by RNAi decreased the migration and invasion of NSCLC cells in vitro and impeded cell metastasis in vivo.
HOXA5 levels were affected by HOTAIR knockdown or over-expression in vitro.
Conclusions: Our findings indicate that HOTAIR is significantly up-regulated in NSCLC tissues, and regulates NSCLC
cell invasion and metastasis, partially via the down-regulation of HOXA5. Thus, HOTAIR may represent a new marker
of poor prognosis and is a potential therapeutic target for NSCLC intervention.
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Non-small cell lung cancer (NSCLC), including adeno-
carcinoma and squamous cell carcinoma, is the predom-
inant form of lung cancer, and accounts for the majority
of cancer deaths worldwide [1]. Despite recent advances
in clinical and experimental oncology, the prognosis of
lung cancer is still unfavorable, with a 5 year overall* Correspondence: zhaoxiawang88@hotmail.com; dewei@njmu.edu.cn
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reproduction in any medium, provided the orsurvival rate of only around 11% [2]. Thus, a detailed
understanding of the mechanisms underlying NSCLC
development and progression are essential for improving
the diagnosis, prevention and treatment of this disease.
Recently, accumulating evidence has shown that non-
coding RNAs (ncRNAs) may be involved in NSCLC
pathogenesis, providing new insights into the biology of
the disease.
Recent improvements in genome-wide surveys and high
throughput transcriptome analysis have revealed that hu-
man genome contains only ~20,000 protein-coding genes,
representing <2% of the total genome while a substantial
fraction of the human genome can be transcripted intoThis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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protein-coding capacity [3,4]. Among the different classes
of ncRNAs, microRNAs have received the most attention
and have been shown to play many important roles in can-
cer via post-transcriptional silencing of specific target
mRNAs [5,6]. However, one of the emerging areas in
ncRNA research is the newly discovered class of long non-
coding RNAs (lncRNAs). The participation of lncRNAs in
a wide repertoire of biological processes has been intensely
researched, because virtually every step of mRNA biology,
from transcription to mRNA splicing, RNA decay and
translation can be influenced by these molecules [7-9].
Multiple lines of evidence link dysregulation of lncRNAs
to diverse human diseases, especially cancers. Several
studies suggest that many lncRNAs can be associated
with chromatin-modifying complexes to affect epigenetic
information and to confer multiple properties that are re-
quired for tumor progression and a metastatic pheno-
type [10-12]. Therefore, identification of cancer-associated
lncRNAs and the interplay between lncRNAs and protein-
coding genes are important topics in the field of cancer
biology, in which lncRNAs may provide a missing piece of
the oncogene and tumor suppressor network puzzle.
HOTAIR (Hox transcript antisense intergenic RNA ) is
one of the few well-documented lncRNAs, with a length
of 2158 bp and a functional role in trans-silencing [13].
Recently, HOTAIR has been determined to be a negative
prognostic indicator in breast, colon, liver, and pancre-
atic cancer patient survival, and increased HOTAIR ex-
pression in patients has been correlated with enhanced
breast and colon cancer metastasis. Meanwhile, HOTAIR
knockdown can inhibit cell invasion and proliferation,
alter cell cycle progression and induce apoptosis, indicat-
ing that HOTAIR can play a direct role in the modulation
of cancer progression [14-17]. Nevertheless, little is known
about the impact of HOTAIR on NSCLC carcinogenesis
or metastasis.
To better understand the role of HOTAIR in NSCLC
development and progression, we investigated the ex-
pression pattern of HOTAIR in NSCLC tissues and ana-
lyzed its relationship to clinical pathological features.
We also explored HOTAIR function during NSCLC pro-
gression using in vitro and in vivo assays and investi-
gated the molecular mechanisms by which HOTAIR
contributes to the phenotypes of NSCLC cells.
Methods
Tissue collection
Forty-two paired NSCLC and adjacent non-tumor lung
tissues were obtained from patients who underwent
surgery at Jiangsu Province Hospital between 2006 and
2007 and were diagnosed with NSCLC (stage II, III, and
IV) based on histopathological evaluation. Clinicopatho-
logical characteristics including tumor-node-metastasis(TNM) stage were collected. No local or systemic treat-
ment was conducted in these patients before surgery. All
collected tissue samples were immediately snap-frozen in
liquid nitrogen and stored at −80°C until use. The study
was approved by the Research Ethics Committee of
Nanjing Medical University, China. Written informed con-
sent was obtained from all patients.
Cell lines and culture conditions
Three NSCLC adenocarcinoma cell lines (A549, SPC-A1,
NCI-H1975), a NSCLC squamous carcinomas cell line
(SK-MES-1), and a normal human bronchial epithelial cell
line (16HBE) were purchased from the Institute of Bio-
chemistry and Cell Biology of the Chinese Academy of
Sciences (Shanghai, China). Cells were cultured in RPMI
1640 or DMEM (GIBCO-BRL) medium supplemented
with 10% fetal bovine serum (FBS), 100 U/ml penicillin
and 100 mg/ml streptomycin (Invitrogen, Carlsbad, CA,
USA) in humidified air with 5% CO2 at 37°C.
RNA extraction and quantitative real-time PCR
Total RNA was extracted from tissues or cultured cells
with TRIzol reagent (Invitrogen) according to the manu-
facturer’s protocol. qRT-PCR assays were performed to
detect HOTAIR expression using the PrimeScript RT re-
agent Kit and SYBR Premix Ex Taq (TaKaRa, Dalian,
China) according to the manufacturer’s instructions. Re-
sults were normalized to the expression of glyceraldehyde-
3-phosphate dehydrogenase (GAPDH). The primers used
were as follows: HOTAIR sense, 5’-CAGTGGGGAACTC
TGACTCG-3′ and antisense, 5′-GTGCCTGGTGCTCTC
TTACC-3′; GAPDH sense, 5′-GGGA GCCAAAAGGG
TCAT-3′ and antisense, 5′-GAGTCCTTCCACGATACC
AA-3′. qRT-PCR and data collection were performed on
an ABI 7500. qRT-PCR results were analyzed and ex-
pressed relative to CT (threshold cycle) values, and then
converted to fold changes.
Plasmid construction
To generate a HOTAIR expression vector, we amplified
a full-length HOTAIR fragment by PCR from SPC-A1
cDNA. Oligonucleotides for amplification of HOTAIR
(sense, 5′-CATGGATCCACATTCTGCCCTGA TTTCC
GGAACC-3′ and antisense, 5′-ACTCTCGAGCCACCA
CACACACACA ACCTACAC-3′) were designed to in-
corporate external HindIII and XhoI sites, respectively.
The PCR product was verified and subcloned into the
mammalian expression vector pCDNA3.1 (Invitrogen).
Cell transfection
Plasmid vectors (pCDNA3.1-HOTAIR and pCDNA3.1-
NC) for transfection were prepared using DNA Midiprep
or Midiprep kits (Qiagen, Hilden, Germany). Three indi-
vidual small interfering RNA (siRNAs) and scrambled
Liu et al. BMC Cancer 2013, 13:464 Page 3 of 10
http://www.biomedcentral.com/1471-2407/13/464negative control siRNA (si-NC) were purchased from
Invitrogen (Invitrogen). The target sequences for HOTAIR
siRNAs were as follows: (si-HOTAIR1, 5′-AAAUCCAGA
ACCCUCUGACAUUUGC-3′, si-HOTAIR2, 5′-UUAAGU
CUA GGAAUCAGCACGAAGC-3′ and si-HOTAIR3, 5′-
CAUAUUAUAGAGUUGCU CUGUGCUG-3′. pCDNA
3.1-HOTAIR or pCDNA3.1-NC was transfected into
cultured A549 cells, and HOTAIR siRNAs or si-NC
were transfected into cultured SPC-A1 cells. A549 and
SPC-A1 cells were grown on six-well plates to confluency
and transfected using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions. Forty-eight
hours after transfection, cells were harvested for qRT-
PCR or western blot analyses.
Cell proliferation assays
Cell proliferation was monitored using Cell Prolifera-
tion Reagent Kit I (MTT) (Roche Applied Science).
Si-HOTAIR-transfected SPC-A1 cells (3000/well), and
pCDNA3.1-HOTAIR-transfected A549 cells (2000/well)
were allowed to grow in 96-well plates. Cell proliferation
was documented every 24 h following the manufacturer’s
protocol. All experiments were performed in quadruplicate.
For the colony formation assay, a total of 500 HOTAIR
siRNA-transfected SPC-A1, or pCDNA3.1-HOTAIR-trans-
fected A549 cells were placed in a fresh six-well plate and
maintained in media containing 10% FBS, replacing the
medium every 4 days. After 14 days, cells were fixed with
methanol and stained with 0.1% crystal violet (Sigma-
Aldrich). Visible colonies were manually counted. For each
treatment group wells were assessed in triplicate.
Flow-cytometric analysis of apoptosis
SPC-A1 cells, transiently transfected with si-HOTAIR or
si-NC, were harvested 48 h after transfection by tryp-
sinization. After double staining with FITC-Annexin V
and propidium iodide, cells were analyzed by flow cy-
tometry (FACScan; BD Biosciences) using CellQuest
software (BD Biosciences). Cells were discriminated into
viable cells, dead cells, early apoptotic cells, and apop-
totic cells, and then the relative ratio of early apoptotic
cells was compared to the control from each experiment.
All samples were assayed in triplicate.
Cell migration and invasion assays
For the migration assays, 48 h after transfection, 5 × 104
cells in serum-free media were placed into the upper
chamber of an insert (8 μm pore size, Millipore). For the
invasion assays, 1 × 105 cells in serum-free medium were
placed into the upper chamber of an insert coated with
Matrigel (Sigma-Aldrich). Media containing 10% FBS
were added to the lower chamber. After incubation for
24 hours, the cells remaining on the upper membrane
were removed with cotton wool, whereas the cells thathad migrated or invaded through the membrane were
stained with methanol and 0.1% crystal violet, imaged,
and counted using an IX71 inverted microscope (Olympus,
Tokyo, Japan). Experiments were independently repeated
three times.
Western blot analysis and antibodies
Cells were lysed using RIPA protein extraction reagent
(Beyotime, Beijing, China) supplemented with a protease
inhibitor cocktail (Roche, CA, USA) and phenylmethyl-
sulfonyl fluoride (Roche). Protein concentration was mea-
sured using the Bio-Rad protein assay kit. Approximately
50 μg of protein extract was separated by 10% SDS-
polyacrylamide gel electrophoresis (SDS-PAGE), then
transferred to nitrocellulose membrane (Sigma) and incu-
bated with specific antibodies. ECL chromogenic substrate
was used to visualize the bands and the intensity of the
bands was quantified by densitometry (Quantity One soft-
ware; Bio-Rad, CA, USA). GAPDH was used as a control.
Antibodies (1:1,000) for HOXA5, E-cadherin, N-cadherin,
vimentin, MMP-2, and MMP-9 were purchased from Cell
Signaling Technology (MA, USA).
Tail vein injection of cells for metastasis in athymic mice
Male athymic mice (5 weeks old) were purchased from
the Animal Center of the Chinese Academy of Science
(Shanghai, China) and maintained in laminar flow cabinets
under specific pathogen-free conditions. SPC-A1 cells
transfected with si-HOTAIR or si-NC were harvested from
6-well cell culture plates, washed with PBS, and resus-
pended at a concentration of 2 × 107 cells/mL. A volume of
0.1 mL of suspended cells was injected into the tail veins of
10 mice. The mice were sacrificed 6 weeks after injection
and the lungs were dissected out, photographed and visible
tumors on the lung surface were counted. This study was
carried out in strict accordance with the recommendations
in the Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health. The protocol was ap-
proved by the Committee on the Ethics of Animal Experi-
ments of Nanjing Medical University (Permit Number:
200933). All surgery was performed under sodium pento-
barbital anesthesia, and all efforts were made to minimize
suffering [18].
Statistical analysis
Student’s t-test (2-tailed), one-way ANOVA, and the
Mann–Whitney U test were conducted to analyze data
using SPSS 16.0 software (IBM, IL, USA). P-values of
less than 0.05 were considered significant.
Results
HOTAIR expression is up-regulated in human NSCLC tissues
The level of HOTAIR was detected in 42 NSCLC samples
and adjacent, histologically normal tissues by qRT-PCR,
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nificantly up-regulated in cancerous tissues compared with
corresponding normal tissues (Figure 1A). Furthermore,
correlation of HOTAIR expression with pathological fea-
tures of NSCLC patients, revealed a significant association
between HOTAIR up-regulation and advanced patho-
logical stage (I/II, n = 25) vs. (III/IV, n = 17) and NSCLC
lymph-node metastasis (Figure 1B and C). However,
HOTAIR expression was not associated with patients’ gen-
der or tumor position (Table 1).
Kaplan-Meier survival analysis and log-rank tests using
patient post-operative survival were performed to further
evaluate the correlation between HOTAIR expression
and NSCLC patient prognosis. According to the median
ratio of relative HOTAIR expression (8.57) in tumor tis-
sues, the 42 NSCLC patients were classified into two
groups: High-HOTAIR group (n = 21): HOTAIR ex-
pression ratio ≥median ratio; and Low-HOTAIR groupFigure 1 Relative HOTAIR expression levels in NSCLC tissues and its c
tissues by qRT-PCR. Data are presented as fold change in tumor tissues rela
in patients at advanced pathological stages. (C) HOTAIR expression was sig
patients with non-lymph node metastasis. (D) Patients with high levels of H
patients with low levels of HOTAIR expression (P <0.001, log-rank test). ** P(n = 21): HOTAIR expression ratio ≤median ratio. The
Kaplan-Meier survival curve showed that patients with
high HOTAIR expression levels had significantly shorter
survival times compared to those with low HOTAIR ex-
pression levels (P <0.001; log-rank test) (Figure 1D). These
findings support the hypothesis that over-expression of
HOTAIR may play a key role in NSCLC progression and
development.
Manipulation of HOTAIR levels in NSCLC cells
We next performed qRT-PCR analysis to examine the
expression of HOTAIR in four human NSCLC cell lines,
including both adenocarcinoma and squamous carcinoma
subtypes. Of these, SPC-A1 and NCI-H1975 expressed
significantly higher levels of HOTAIR compared with
the normal bronchial epithelial cell line (16HBE), while
A549 cells expressed relatively low levels of HOTAIR
(Figure 2A).linical significance. (A) HOTAIR was detected in 42 pairs of NSCLC
tive to normal tissues. (B) HOTAIR expression was significantly higher
nificantly higher in patients with lymph node metastasis than in
OTAIR expression showed reduced survival times compared with
< 0.01.




n (%) Relative expression
of HOTAIRa
P-valueb
Gender P = 0.783
Male 32 (76) 11.43
Female 10 (24) 10.21
Site of tumor P = 0.856
Left lung 18 (43) 8.23
Right lung 24 (57) 9.54
Differentiation P = 0.238
Poor 24 (57) 12.8
High/moderate 18 (43) 7.9
Lymph node Metastasis P = 0.005
N0 8 (19) 1.78
N1 8 (19) 2.59
N2 10 (24) 10.6
N3 16 (38) 30.34
aMedian of relative expression. bP < 0.05 was considered significant (Mann-Whitney
U test between 2 groups and Kruskall-Wallis test for 3 groups).
Figure 2 HOTAIR expression levels in NSCLC cell lines. (A) qRT-PCR an
NCI-H1650 and SK-MES-1) compared with the normal bronchial epithelial c
treatment of SPC-A1 cells with three individual siRNAs targeting HOTAIR an
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NSCLC cells, we modulated its expression through RNA
interference and over-expression experiments. pCDNA3.1-
HOTAIR was transfected into A549 cells and three individ-
ual HOTAIR siRNAs were transfected into SPC-A1 cells.
qRT-PCR analysis of HOTAIR levels was performed 48 h
post-transfection. HOTAIR expression was increased
97-fold in A549 cells, compared with control cells. In
SPC-A1 cells, when compared with control cells (si-NC),
HOTAIR expression was knocked down by 75% by si-
HOTAIR3, the most effective siRNA. Thus, si-HOTAIR3
was used in subsequent experiments (Figure 2B and C).
Effect of HOTAIR on cell proliferation and apoptosis
To assess the role of HOTAIR in NSCLC, we investigated
the effect of targeted knockdown or over-expression of
HOTAIR on cell proliferation and apoptosis. MTT assays
revealed that cell growth was not influenced in SPC-A1
cells transfected with si-HOTAIR compared with controls
(Figure 3A). Similarly, colony-formation assays revealed
that clonogenic survival was not changed following inhib-
ition of HOTAIR in SPC-A1 cells (Figure 3B). Consistentalysis of HOTAIR expression levels in NSCLC cell lines (A549, SPC-A1,
ell line (16HBE). (B, C) qRT-PCR analysis of HOTAIR expression following
d of A549 cells transfected with pCDNA-HOTAIR. *P < 0.05, **P < 0.01.
Figure 3 Effect of HOTAIR on cell proliferation and apoptosis. (A, B) SPC-A1 cells were transfected with si-HOTAIR or si-NC. MTT assays were
performed to determine the proliferation of SPC-A1 cells. Data represent the mean ± S.D. from three independent experiments. Colony-forming
growth assays were performed, also to determine the proliferation of SPC-A1 cells. The colonies were counted and captured. (C) SPC-A1 cells
were transfected with si-HOTAIR or si-NC. Apoptotic rates were detected by flow cytometry. UL, necrotic cells; UR, terminal apoptotic cells; LR,
early apoptotic cells. **P < 0.01.
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A549 cells also had no significant effect on cell prolifera-
tion compared with control cells (data not shown).
We then tested the effect of HOTAIR on apoptosis.
SPC-A1 cells were seeded in six-well plates and trans-
fected with si-HOTAIR or si-NC. We conducted apoptosis
assays using an annexin V-propidium iodide apoptosis de-
tection kit to determine whether knockdown of HOTAIR
induces NSCLC cell apoptosis. The results shown in
Figure 3C demonstrated a significantly higher percentage
of apoptotic cells for si-HOTAIR-treated cells compared
to those transfected with the untargeted-control (si-NC).
Taken together, these results indicate that inhibition of
HOTAIR induces NSCLC cells apoptosis, but has no ef-
fect on cell vitality.
HOTAIR promotes migration and invasion of NSCLC cells
Cell invasion is a significant aspect of cancer progression,
and involves the migration of tumor cells into contiguous
tissues and the dissolution of extracellular matrix proteins.To investigate whether HOTAIR has a direct functional
role in facilitating NSCLC cell migration and invasion, we
evaluated cancer cell invasion through Matrigel and migra-
tion through a transwell. As shown in Figure 4A, inhibition
of HOTAIR impeded the migration of SPC-A1 cells by ap-
proximately 68% compared with control. Similarly, inva-
sion of SPC-A1 cells was reduced by 65% following
inhibition of HOTAIR. Conversely, transfection of A549
cells with pCDNA-HOTAIR promoted cell migration and
invasion ability ~1.9-fold (Figure 4B). These data indicate
that HOTAIR can promote the migratory and invasive
phenotype of NSCLC cells.
HOTAIR promotes NSCLC cell metastasis in vivo
To validate the effect of HOTAIR on metastasis of
NSCLC cells in vivo, SPC-A1 cells transfected with si-
HOTAIR were injected into an athymic mouse xenograft
model via the tail vein. The metastatic nodules on the sur-
face of lungs were counted after 6 weeks. Inhibition of
HOTAIR expression resulted in a significant reduction in
Figure 4 Effect of HOTAIR on cell migration, invasion and metastasis. (A, B) SPC-A1 cells were transfected with HOTAIR siRNA or si-NC, and A549
cells were transfected with pCDNA-HOTAIR or pCDNA-NC. Transwell assays were performed to investigate the migratory and invasive ability of NSCLC
cells. (C) Analysis of an experimental metastasis animal model was performed by injecting HOTAIR knockdown SPC-A1 cells into nude mice through the
lateral tail vein. Images of lungs from mice in each experimental group are shown. The numbers of tumor nodules on lung surfaces are shown. ** P< 0.01.
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trol group (Figure 4C). This in vivo data complemented
the functional in vitro studies of HOTAIR, and demon-
strated that HOTAIR was capable of promoting NSCLC
cell metastasis in vivo.
HOTAIR affects the levels of MMP2, MMP9 and HOXA5
proteins
To explore the molecular mechanisms by which HOTAIR
contributes to the phenotypes of NSCLC cells, weinvestigated potential targets involved in tumor invasion
and metastasis. Often, cancer cells undergo morphological
alterations and change their cell-cell or cell-matrix inter-
actions. The epithelial- mesenchymal transition (EMT) is
an important event in the progression of tumor invasion
and metastasis. In this study, western blot assays were
performed to detect the expression of EMT-induced
markers (E-cadherin, N-cadherin and Vimentin) between
HOTAIR knockdown SPC-A1 cells and control cells.
These results revealed no significant difference between
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Matrix metalloproteinases (MMPs) have a pivotal role in
the degradation of extracellular matrix (ECM) proteins,
and thereby enhance the invasive, proliferative and meta-
static potential of cancer. Therefore, we next sought to
determine whether there was any interaction between
MMPs and HOTAIR. As expected, clear reductions in
the levels of MMP2 and MMP9 proteins were observed
that correlated with the inhibition of HOTAIR in SPC-
A1 cells. In addition, suppression of HOTAIR in SPC-A1
cells induced the up-regulation of HOXA5 protein, which
is involved in NSCLC cell migration and invasion. Con-
versely, over-expression of HOTAIR in A549 cells resulted
in down-regulation of HOXA5 protein (Figure 5A). These
data indicate that HOTAIR may influence the invasive and
metastatic potential of NSCLC cells by altering MMPs and
HOXA5 expression, but not by deregulating the expression
of EMT-induced markers.
Discussion
NSCLC ranks among the most common and lethal ma-
lignant diseases. Poor prognosis of early stage NSCLC
is crucially linked to the onset of tumor metastasis
[19]. The processes inducing and stimulating metasta-
sis are complex and still not well understood. Schmidt
et al. have established a role for lncRNA in metastasisFigure 5 HOTAIR affects MMP2, MMP9 and HOXA5 protein levels. (A)
and Vimentin) and matrix metalloproteinases (MMP-2 and MMP-9) in HOTA
of HOXA5 following treatment of SPC-A1 cells with si-HOTAIR and of A549
internal control. * P < 0.05; ** P < 0.01.formation in NSCLC. They identified the lncRNA,
MALAT1 (Metastasis-Associated Lung Adenocarcinoma
Transcript 1), as a prognostic marker for metastasis and
patient survival in NSCLC [20]. However, the roles of
lncRNAs in the carcinogenesis of NSCLC are far from be-
ing fully elucidated.
In this paper, we have investigated the involvement of
the lncRNA, HOTAIR, in NSCLC carcinogenesis and
metastasis. HOTAIR was initially identified as one of
231 lncRNAs associated with the human HOX loci,
which, however, can repress transcription in trans across
40 kilobases of the HOXD locus in foreskin fibroblasts
[21]. Notably, HOTAIR over-expression targets polycomb
repressive complex 2 (PRC2), a complex comprised of
EZH2, SUZ12 and EED. This has a genome-wide effect,
serving to alter H3K27 methylation and gene expression
patterns, thus increasing cancer invasiveness and metasta-
sis. Conversely, knockdown of HOTAIR or PRC2 compo-
nent expression can inhibit cancer invasiveness [15,17].
HOTAIR can also interact with a second histone modifica-
tion complex, the LSD1/CoREST/REST complex, which
coordinates the targeting of PRC2 and LSD1 to chromatin
for coupled histone H3K27 methylation and K4 demethyl-
ation [22]. Given its important role in the epigenetic regu-
lation of gene expression, it is not surprising that HOTAIR
is deregulated in different types of cancer [14-17,23,24].Western blot analysis of EMT-induced markers (E-cadherin, N-cadherin
IR knockdown SPC-A1 cells and control cells. (B) Western blot analysis
cells transfected with pCDNA-HOTAIR. GAPDH protein was used as an
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oncogenic role in NSCLC.
The current study indicated that the expression of
HOTAIR was dramatically upregulated in NSCLC tissues
compared with normal tissues. Specifically, HOTAIR ex-
pression was found to be significantly higher at later stages
of tumor development and in tumors that had undergone
extensive metastasis. Moreover, the overall survival time of
patients with lower HOTAIR expression levels was signifi-
cantly longer than that of patients with higher HOTAIR
expression levels. These findings indicate that HOTAIR
plays a direct role in the modulation of cancer progression,
and may be useful as a novel prognostic or progression
marker for NSCLC.
To further assess the role of HOTAIR in NSCLC, we
investigated the effects of gain or loss of function of
HOTAIR on various aspects of NSCLC biology. First,
we demonstrated that RNAi-mediated suppression of
HOTAIR in SPC-A1 cells led to a significant inhibition of
migration and invasion, and to the promotion of apoptosis.
Conversely, introducing HOTAIR into A549 cells, which
express relatively low levels of endogenous HOTAIR, in-
duced malignant tumor cell behaviors. To further quantify
metastatic potential in vivo, we performed tail vein xeno-
grafts and compared the rates of lung colonization. The in-
hibition of HOTAIR expression resulted in a significant
reduction in the number of lung metastatic nodules. In
conclusion, HOTAIR knockdown can inhibit the invasion
and metastasis of NSCLC in vitro and in vivo; thus,
HOTAIR represents a new prognosis marker and a prom-
ising target for NSCLC treatment.
To explore the molecular mechanism by which HOTAIR
contributes to the invasion and metastasis of NSCLC, we
investigated potential target proteins involved in cell motil-
ity and matrix invasion. Firstly, a hallmark of EMT is the
loss of E-cadherin expression and aberrant expression of
N-cadherin and Vimentin [25-28]. Therefore, the protein
levels of these EMT-induced markers were investigated
after HOTAIR depletion. However, our results indicated
that the inhibitory effects on cell migration and invasion
were not associated with the epithelial-mesenchymal tran-
sition. Metalloproteases (MMPs) are important in many
aspects of biology, ranging from cell proliferation, differen-
tiation and remodeling of the extracellular matrix (ECM)
to vascularization and cell migration [29]. Here, loss of
HOTAIR in NSCLC cells led to a significant decrease in
MMP2 and MMP9 protein levels, and the relationship be-
tween HOTAIR and MMPs is currently under further in-
vestigation in our laboratory.
Of note, HOTAIR can epigenetically regulate HOXD
expression, such as HOXD10, by targeting PRC2, leading
to H3K27me3 [14,30]. Here, we found that HOTAIR can
suppress HOXA5 protein levels, another member of the
HOX family. HOXA5 is involved in the developmentalregulation of the lung. Mandeville et al. observed im-
paired postnatal lung development in HoxA5−/− mice,
indicating that HOXA5 has a critical role in lung on-
togeny, and implying an involvement in lung maturation
and function [31]. Similarly, Packer et al. reported that
HOXA5 is likely to be involved in the development and
patterning of the mouse lung [32]. Moreover, dys-
regulation of HOXA5 expression has been associated with
lung tumorigenesis and other diseases in humans [33-35].
In our previously study, we found that HOXA5 was signifi-
cantly downregulated in NSCLC tissues and inhibition of
HOXA5 expression in A549 cells significantly promotes
cell migration and invasion [36]. Consistent with the above
findings, ectopic HOTAIR expression in A549 cells also
induced corresponding malignant tumor cell behaviors.
Taken together, these results indicate that the oncogenic
functions of HOTAIR may be partially exerted through its
affect on the expression of HOXA5; however, further ex-
periments are needed to elucidate the precise molecular
mechanisms by which HOTAIR regulates HOXA5.
Conclusions
In summary, HOTAIR upregulation may be a negative
prognostic factor for NSCLC patients, indicative of poor
survival rates and higher risk for cancer metastasis. The
current study showed that HOTAIR may regulate the inva-
sion ability of NSCLC cells, partially through regulation of
HOXA5 expression. These findings further the under-
standing of NSCLC pathogenesis and development, and fa-
cilitate the development of lncRNA-directed diagnostics
and therapeutics against this deadly disease.
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